ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,297.10
-0.21%
Dow Jones
39,869.38
-0.10%
US Dollar vs MXN
16.6838
0.02%
Brent Oil
82.95
-0.31%
Bitcoin
66,279.13
1.59%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Catabasis Pharmaceuticals Inc (CATB)

  7. Catabasis Pharmaceuticals Inc (CATB) Noticias

CATB

Catabasis Pharmaceuticals (CATB)

Catabasis Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CATB
FechaHoraFuenteTítuloSímboloCompañía
06/06/202307:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
24/05/202305:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CATBCatabasis Pharmaceuticals Inc
11/05/202315:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CATBCatabasis Pharmaceuticals Inc
20/04/202315:05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CATBCatabasis Pharmaceuticals Inc
20/04/202315:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
19/04/202307:09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/04/202315:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
31/03/202307:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
14/02/202314:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/01/202311:49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
21/12/202215:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
15/12/202216:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
21/06/202207:34Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
13/05/202205:08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CATBCatabasis Pharmaceuticals Inc
27/04/202207:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/03/202215:46Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/02/202215:10Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
08/09/202107:00Business WireCatabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company FocusNASDAQ:CATBCatabasis Pharmaceuticals Inc
09/08/202115:10Business WireCatabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate UpdateNASDAQ:CATBCatabasis Pharmaceuticals Inc
04/08/202107:00Business WireCatabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare ConferenceNASDAQ:CATBCatabasis Pharmaceuticals Inc
07/07/202107:00Business WireCatabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare ConferenceNASDAQ:CATBCatabasis Pharmaceuticals Inc
17/06/202112:42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/06/202115:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
14/05/202107:00Business WireCatabasis Pharmaceuticals To Present At Upcoming Investor ConferencesNASDAQ:CATBCatabasis Pharmaceuticals Inc
13/05/202115:10Business Wire Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate UpdateNASDAQ:CATBCatabasis Pharmaceuticals Inc
11/03/202115:35Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CATBCatabasis Pharmaceuticals Inc
11/03/202115:10Business WireCatabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate UpdateNASDAQ:CATBCatabasis Pharmaceuticals Inc
02/03/202107:00Business WireCatabasis Pharmaceuticals To Present At Upcoming Investor Conferences   NASDAQ:CATBCatabasis Pharmaceuticals Inc
08/02/202115:52Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:CATBCatabasis Pharmaceuticals Inc
29/01/202107:00Business WireCatabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.NASDAQ:CATBCatabasis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CATB

Su Consulta Reciente

USOTC
MNXBF
Monex (PK)
AQSE
IQE.GB
IQE
BSTP
OMGBTC
OMG Network
NASDAQ
AAXSJXX
Gs Finance Corp Autocall...
AMEX
IQHI
IQ Mackay ESG High Incom...
NASDAQ
UTVUX
Small Cap Value Index In...
NYSE
SRG-A
Seritage Growth Properties
COIN
PERLETH
Perlin
NASDAQ
IACIZ
Iac/Interactivecorp
KUCN
USDCBTC
USD Coin
USOTC
MBGPF
Moberg Pharma AB (PK)
HITB
SWTETH
Swarm City
COIN
STBBTC
LSE
GBP
Global Petroleum
COIN
21MEUR
NASDAQ
AAYDMXX
Jpmorgan Chase Financial...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados